Clinical Trials Browser

INDUSTRY × trebananib × Genitourinary × Clear all

NCT01331941 2017-11-06

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Phase 1 Completed

Kidney Diseases, Renal Insufficiency

NCT00467025 2016-03-23

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Phase 2 Completed

Carcinoma, Renal Cell